Followup on unsterile, intermittent self-catheterization.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D000985:Antisepsis; D001437:Bacteriuria / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003556:Cystitis / Q000628:therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use; D011312:Pressure; D011470:Prostatic Hyperplasia / Q000628:therapy; D011704:Pyelonephritis / Q000628:therapy; D014521:Urethra; D014526:Urethritis; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy; D014546:Urinary Catheterization; D014549:Urinary Incontinence / Q000628:therapy; D014552:Urinary Tract Infections / Q000517:prevention & control*; D014554:Urination
D000892:Anti-Infective Agents, Urinary; D010276:Parasympatholytics; D010277:Parasympathomimetics